|
JP2004529934A
(ja)
*
|
2001-05-01 |
2004-09-30 |
アンジオテック ファーマシューティカルズ，インコーポレイテッド |
抗微小管剤およびポリペプチドまたはポリサッカリドを含む組成物、ならびに炎症状態を処置するための医薬品の調製のためのそれらの組成物の使用
|
|
US20030157161A1
(en)
*
|
2001-05-01 |
2003-08-21 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
|
|
US7354574B2
(en)
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
US7326256B2
(en)
|
2002-12-06 |
2008-02-05 |
L'ORéAL S.A. |
Composition for the oxidation dyeing of keratin fibers, comprising at least one non-oxyalkenylated fatty alcohol, at least one oxidation dye, at least one associative polymer, and at least one amide of an alkanolamine and a C14-C30 fatty acid
|
|
FR2848106B1
(fr)
*
|
2002-12-06 |
2006-11-17 |
Oreal |
Composition de teinture pour fibres keratiniques comprenant un alcool gras non oxyalkylene, un colorant d'oxydation, un polymere associatif et un amide d'une alcanolamine et d'un acide gras en c14-c30.
|
|
JP2004262777A
(ja)
*
|
2003-02-27 |
2004-09-24 |
Shiseido Co Ltd |
アセチル化ヒアルロン酸含有眼用医薬組成物
|
|
US20050196370A1
(en)
*
|
2003-03-18 |
2005-09-08 |
Zhi-Jian Yu |
Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
|
|
AU2003228126A1
(en)
*
|
2003-05-02 |
2004-11-23 |
Arturo Jimenez Bayardo |
Method of preparing an aqueous solution of cyclosporin-a and resulting aqueous solution
|
|
US7947295B2
(en)
*
|
2003-06-13 |
2011-05-24 |
Alcon, Inc. |
Ophthalmic compositions containing a synergistic combination of two polymers
|
|
US7083802B2
(en)
|
2003-07-31 |
2006-08-01 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
JP2007505932A
(ja)
|
2003-09-18 |
2007-03-15 |
マクサイト， インコーポレイテッド |
経強膜送達
|
|
US7083803B2
(en)
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
US7087237B2
(en)
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
EP1706095B1
(en)
*
|
2004-01-20 |
2008-12-24 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
|
US7135455B2
(en)
*
|
2004-11-15 |
2006-11-14 |
Allergan, Inc |
Methods for the therapeutic use of cyclosporine components
|
|
WO2006067608A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Laboratoire Medidom S.A. |
Aqueous formulations based on sodium hyaluronate for parenteral use
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
CA2597590A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
CN100478025C
(zh)
*
|
2005-03-25 |
2009-04-15 |
中国科学院上海药物研究所 |
一种环孢菌素a眼用微乳制剂及其制备方法
|
|
WO2007003481A1
(en)
*
|
2005-07-01 |
2007-01-11 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops
|
|
WO2007011880A2
(en)
|
2005-07-18 |
2007-01-25 |
Minu, L.L.C. |
Enhanced ocular neuroprotection/neurostimulation
|
|
US20070014760A1
(en)
*
|
2005-07-18 |
2007-01-18 |
Peyman Gholam A |
Enhanced recovery following ocular surgery
|
|
US7501393B2
(en)
*
|
2005-07-27 |
2009-03-10 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
|
US20080306022A1
(en)
*
|
2005-10-12 |
2008-12-11 |
Kenji Miyamoto |
Agent for Applying to Mucosa and Method for the Production Thereof
|
|
US9839667B2
(en)
|
2005-10-14 |
2017-12-12 |
Allergan, Inc. |
Prevention and treatment of ocular side effects with a cyclosporin
|
|
US7745400B2
(en)
*
|
2005-10-14 |
2010-06-29 |
Gregg Feinerman |
Prevention and treatment of ocular side effects with a cyclosporin
|
|
US8067433B2
(en)
*
|
2005-11-09 |
2011-11-29 |
Zalicus Inc. |
Methods, compositions, and kits for the treatment of ophthalmic disorders
|
|
HUE028588T2
(hu)
|
2005-12-13 |
2016-12-28 |
Incyte Holdings Corp |
Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
|
|
KR101478164B1
(ko)
|
2006-02-09 |
2014-12-31 |
산텐 세이야꾸 가부시키가이샤 |
안정한 제제와 그 제조 및 사용 방법
|
|
US7655625B2
(en)
|
2006-02-13 |
2010-02-02 |
Allergan, Inc. |
Methods of treating blepharospasm using cyclosporine components
|
|
US20070212420A1
(en)
*
|
2006-03-10 |
2007-09-13 |
Bausch & Lomb Incorporated |
Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
|
|
AU2007230964B2
(en)
|
2006-03-23 |
2012-07-19 |
Santen Pharmaceutical Co., Ltd. |
Formulations and methods for vascular permeability-related diseases or conditions
|
|
EP2043628A4
(en)
*
|
2006-06-27 |
2009-11-25 |
Riolan Technologies Inc |
ULTRAVIOLET ABSORBENT OPHTHALMIC COMPOSITIONS
|
|
US9561178B2
(en)
*
|
2006-07-25 |
2017-02-07 |
Allergan, Inc. |
Cyclosporin compositions
|
|
AU2016203191B2
(en)
*
|
2006-07-25 |
2018-03-01 |
Allergan, Inc. |
Cyclosporin compositions
|
|
WO2008035246A2
(en)
|
2006-07-28 |
2008-03-27 |
Novagali Pharma Sa |
Compositions containing quaternary ammonium compounds
|
|
CN101896160A
(zh)
*
|
2006-10-17 |
2010-11-24 |
阿勒根公司 |
环胞菌素组合物
|
|
EP2139492A1
(en)
*
|
2007-03-30 |
2010-01-06 |
Fovea Pharmaceuticals SA |
Methods for treating neovascular ocular diseases
|
|
EP2740731B1
(en)
|
2007-06-13 |
2016-03-23 |
Incyte Holdings Corporation |
Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
|
JP5668476B2
(ja)
|
2007-10-08 |
2015-02-12 |
オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物
|
|
CA2702082A1
(en)
*
|
2007-10-08 |
2009-04-16 |
Fovea Pharmaceuticals Sa |
Aqueous ophthalmic formulations
|
|
US20100016219A1
(en)
*
|
2008-07-19 |
2010-01-21 |
Jerry Zhang |
Ophthalmic compositions containing solubilized cyclosporin
|
|
CL2009001884A1
(es)
*
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
GB0904423D0
(en)
*
|
2009-03-14 |
2009-04-29 |
Univ Strathclyde |
Improving the solubility of chemicals
|
|
NZ596479A
(en)
|
2009-05-22 |
2014-01-31 |
Incyte Corp |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
BRPI1012108B8
(pt)
|
2009-05-22 |
2021-05-25 |
Incyte Corp |
composto 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octa no- ou heptano-nitrila, sua composição, seus usos e processo para preparar um sal de ácido fosfórico
|
|
EP2440185B1
(en)
|
2009-06-09 |
2015-04-08 |
Aurinia Pharmaceuticals Inc. |
Topical drug delivery systems for ophthalmic use
|
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
CA2792508C
(en)
|
2010-03-10 |
2018-01-16 |
Incyte Corporation |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors
|
|
EA202091303A3
(ru)
|
2010-05-21 |
2021-05-31 |
Инсайт Холдингс Корпорейшн |
Композиция ингибитора jak для местного применения
|
|
ES2536415T3
(es)
|
2010-11-19 |
2015-05-25 |
Incyte Corporation |
Pirrolopiridinas y pirrolopirimidinas sustituidas heterocíclicas como inhibidores de JAK
|
|
CA2818542A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
US8691807B2
(en)
|
2011-06-20 |
2014-04-08 |
Incyte Corporation |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
KR102029513B1
(ko)
*
|
2011-11-15 |
2019-10-07 |
알러간, 인코포레이티드 |
사이클로스포린 제2형의 지속 작용 제형
|
|
CN108714137B
(zh)
*
|
2011-11-15 |
2022-02-01 |
阿勒根公司 |
环孢菌素a形式2的可热压性悬浮液
|
|
FR2988297B1
(fr)
*
|
2012-03-22 |
2014-03-28 |
Thea Lab |
Solution ophtalmique aqueuse a base de ciclosporine a sans conservateur
|
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
|
KR102242077B1
(ko)
|
2012-11-15 |
2021-04-20 |
인사이트 홀딩스 코포레이션 |
룩솔리티니브의 서방성 제형
|
|
EP3489239B1
(en)
|
2013-03-06 |
2021-09-15 |
Incyte Holdings Corporation |
Processes and intermediates for making a jak inhibitor
|
|
PT3613423T
(pt)
|
2013-07-10 |
2022-12-07 |
Matrix Biology Inst |
Composições de hialuronano de elevada elasticidade e suas utilizações
|
|
MX376856B
(es)
|
2013-08-07 |
2025-03-07 |
Incyte Holdings Corp |
Formas de dosificacion de liberacion prolongada para un inhibidor de jak 1 (cinasa de janus 1).
|
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
|
RU2713953C2
(ru)
|
2014-07-18 |
2020-02-11 |
Аллерган, Инк. |
Суспензионные составы циклоспорина а для субконъюнктивального и периокулярного введения
|
|
PT3352766T
(pt)
|
2015-09-24 |
2022-03-22 |
Matrix Biology Inst |
Composições de hialuronano de elevada elasticidade e processos para o seu uso
|
|
KR101635915B1
(ko)
*
|
2016-02-15 |
2016-07-04 |
삼천당제약주식회사 |
사이클로스포린과 히알루론산 또는 이의 염을 포함하는 수용액 형태의 안과용 조성물
|
|
ES2909998T3
(es)
*
|
2016-10-14 |
2022-05-11 |
I Com Medical Gmbh |
Método para establecer, restablecer y preservar la homeostasis de la superficie ocular
|
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
|
US11766421B2
(en)
|
2017-09-25 |
2023-09-26 |
Surface Ophthalmics, Inc. |
Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
|
|
TW201924683A
(zh)
|
2017-12-08 |
2019-07-01 |
美商英塞特公司 |
用於治療骨髓增生性贅瘤的低劑量組合療法
|
|
MD3746429T2
(ro)
|
2018-01-30 |
2022-08-31 |
Incyte Corp |
Procedee pentru prepararea de (1-(3-fluoro-2-(trifluorometil)izonicotinil)piperidin-4-onă)
|
|
KR20210100005A
(ko)
*
|
2018-03-29 |
2021-08-13 |
마티 테라퓨틱스 인코포레이티드 |
안과 약제의 서방성 제형 및 건성 증후군 치료 용도
|
|
KR20260080448A
(ko)
|
2018-03-30 |
2026-06-02 |
인사이트 코포레이션 |
Jak 억제제를 사용하는 화농성 한선염의 치료
|
|
JP2022516099A
(ja)
|
2018-12-27 |
2022-02-24 |
サーフィス オフサルミクス，インコーポレイテッド |
眼科用医薬組成物及び癌表面疾患の処置方法
|
|
US20220378698A1
(en)
|
2019-07-12 |
2022-12-01 |
Pharmathen S.A. |
Preservative free pharmaceutical composition for ophthalmic administration containing cyclosporine
|
|
TW202131926A
(zh)
|
2019-11-22 |
2021-09-01 |
美商英塞特公司 |
包含alk2抑制劑及jak2抑制劑的組合療法
|
|
WO2021120937A1
(zh)
*
|
2019-12-17 |
2021-06-24 |
童妍(上海)医疗器械有限公司 |
转甲状腺素蛋白进入眼内以及在制备滴剂中的应用
|
|
JP2023518972A
(ja)
*
|
2020-03-23 |
2023-05-09 |
キオラ ファーマシューティカルズ，インコーポレイティド |
眼病態の治療のための組成物及び方法
|
|
GR1010012B
(el)
|
2020-05-12 |
2021-05-27 |
Φαρματεν Α.Β.Ε.Ε. |
Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον κυκλοσπορινη
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
US11484538B2
(en)
*
|
2020-08-26 |
2022-11-01 |
Somerset Therapeutics, Llc |
Bromfenac, prednisolone, and moxifloxacin compositions and methods
|
|
US12102632B2
(en)
|
2020-08-26 |
2024-10-01 |
Somerset Therapeutics, Llc |
Quinolone dispersions
|
|
US12440510B2
(en)
|
2021-05-10 |
2025-10-14 |
Surface Ophthalmics, Inc. |
Use of chondroitin sulfate for relieving ocular pain
|
|
CN117979951A
(zh)
|
2021-05-10 |
2024-05-03 |
瑟菲斯眼科股份有限公司 |
一种用于缓解眼部疼痛的硫酸软骨素的用途
|
|
CA3262457A1
(en)
*
|
2022-07-20 |
2025-06-12 |
Asahi Kasei Kabushiki Kaisha |
PHARMACEUTICAL COMPOSITION BASED ON A HYALURONIC ACID DERIVATIVE, AND PROCESS FOR PRODUCING THE PHARMACEUTICAL COMPOSITION
|